advertisement
Bator G 1
Showing records 1 to 1 | Display all abstracts from Bator G122201 A phase III, multicentre, randomised, investigator-masked, cross-over, comparative, non-inferiority trial evaluating the efficacy and tolerability of generic preservative-free Latanoprost (Polpharma S.A.) compared to Xalatan (Pfizer) in patients with ocul
Czumbel N; Acs T; Bator G; Halmosi A; Egorov EA; Maltsev DS
BMC Ophthalmology 2024; 24: 313
